EurekAlert! Cancer Research - News Releases

News Releases

Updates every hour. Last Updated: 9-Jul-2025 10:10 ET (9-Jul-2025 14:10 GMT/UTC)

A dental floss that can measure stress

Tufts University
Peer-Reviewed Publication

Scientists create a floss pick that samples cortisol within saliva as a marker of stress and quantifies it with a built-in electrode. The system uses a polymer casting technology that can be adapted to capture a wide a range of markers, such as estrogen for tracking fertility, or glucose for tracking diabetes. Ease of use allows monitoring to be incorporated into many areas of treatment

Journal: ACS Applied Materials & Interfaces
Funder: U.S. National Science Foundation, DoD Peer Review Medical Research Program, Uniformed Services University of Health Sciences

Immune side effects of liver cancer therapy studied in Latin American patients

Impact Journals LLC
Peer-Reviewed Publication

BUFFALO, NY – May 23, 2025 – A new research paper was published in Volume 16 of Oncotarget on May 19, 2025, titled “Immune-mediated adverse events following atezolizumab and bevacizumab in a multinational Latin American cohort of unresectable hepatocellular carcinoma.”

Journal: Oncotarget

ESMO releases version 2.0 of the Magnitude of Clinical Benefit Scale

European Society for Medical Oncology
Reports and Proceedings

The European Society for Medical Oncology (ESMO) is pleased to announce the publication of the latest version of the scale that measures the clinical benefit of cancer treatments, the ESMO-MCBS (ESMO-Magnitude of Clinical Benefit Scale).

Venous thromboembolism in children: Rivaroxaban effective and safe even with extended use

Medical University of Vienna
Peer-Reviewed Publication

Venous thromboembolism (VTE) is a life-threatening complication in children with serious underlying conditions such as heart defects or cancer. Treatment or prevention of thrombosis poses an additional challenge in everyday clinical practice. A therapy using the active ingredient rivaroxaban specifically tailored to children was successfully tested for the first time in 2020. Now, long-term data confirm the benefits of this drug treatment even for extended use. The study was conducted by an international research team led by MedUni Vienna and has been published in the journal The Lancet Haematology.

Journal: The Lancet Haematology

Autophagy and lysosomal pathways orchestrate unconventional secretion of Parkinson’s disease protein

Doshisha University
Peer-Reviewed Publication

Proteins are conventionally trafficked and secreted extracellularly via the endoplasmic reticulum-Golgi pathway. Some proteins that bypass this system and use unconventional mechanisms to exit the cell have been implicated in neurodegenerative diseases, inflammation, and cancer. Researchers from Japan have elucidated a novel role of autophagy mediated by the formation of “secretory autolysosomes” in the release of PARK7—a protein associated with Parkinson’s disease (PD). Their findings uncover potential pathogenic mechanisms, early biomarkers, and therapeutic targets.

Journal: Proceedings of the National Academy of Sciences

“Digital tumors” for precision oncology: UC San Diego receives award from ARPA-H

University of California - San Diego
Grant and Award Announcement

As part of ARPA-H's landmark ADAPT initiative, UC San Diego researchers will develop cutting-edge tools for precision oncology that act as "digital tumors," predicting treatment response and responding to changes in disease course.

Penn Medicine at the 2025 ASCO Annual Meeting

University of Pennsylvania School of Medicine
Reports and Proceedings

Penn Medicine researchers will present data on the latest advances in cancer science and medicine at the 2025 ASCO Annual Meeting.

Meeting: 2025 ASCO Annual Meeting

City of Hope researchers to present cancer advances that could boost survival at the American Society of Clinical Oncology (ASCO) Annual Meeting

City of Hope
Reports and Proceedings

City of Hope will present novel cancer treatment approaches and combinations, leading-edge targeted therapies, and supportive care interventions at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting taking place May 30 to June 3 in Chicago and online.

ASCO: MD Anderson researchers present high-impact studies across multiple cancers

University of Texas M. D. Anderson Cancer Center
Reports and Proceedings

Researchers from The University of Texas MD Anderson Cancer Center will present research at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting. These oral presentations address multiple tumor types and highlight key studies in immunotherapy, targeted therapy, and treatment strategies for aggressive and rare cancers.

Ritu Banga Healthcare Disparities Research Awards support innovative science

Weill Cornell Medicine
Grant and Award Announcement

Four Weill Cornell Medicine investigators received the Ritu Banga Healthcare Disparities Research Awards, recognizing innovative research that will help close care gaps in clinical settings.

53
54
55
56
57